State Street’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223M | Buy |
19,773,480
+911,827
| +5% | +$10.3M | 0.01% | 830 |
|
|
2025
Q1 | $190M | Sell |
18,861,653
-1,940,059
| -9% | -$19.6M | 0.01% | 916 |
|
|
2024
Q4 | $246M | Buy |
20,801,712
+1,240,463
| +6% | +$14.7M | 0.01% | 814 |
|
|
2024
Q3 | $226M | Buy |
19,561,249
+1,118,561
| +6% | +$12.9M | 0.01% | 841 |
|
|
2024
Q2 | $195M | Buy |
18,442,688
+1,289,554
| +8% | +$13.6M | 0.01% | 869 |
|
|
2024
Q1 | $181M | Buy |
17,153,134
+3,425,716
| +25% | +$36.1M | 0.01% | 923 |
|
|
2023
Q4 | $154M | Buy |
13,727,418
+3,406,626
| +33% | +$38.3M | 0.01% | 1007 |
|
|
2023
Q3 | $121M | Buy |
10,320,792
+786,896
| +8% | +$9.19M | 0.01% | 1059 |
|
|
2023
Q2 | $96.1M | Buy |
9,533,896
+1,500,944
| +19% | +$15.1M | 0.01% | 1248 |
|
|
2023
Q1 | $59.3M | Buy |
8,032,952
+4,525,910
| +129% | +$33.4M | ﹤0.01% | 1534 |
|
|
2022
Q4 | $28M | Buy |
3,507,042
+2,601,911
| +287% | +$20.8M | ﹤0.01% | 2007 |
|
|
2022
Q3 | $2.92M | Sell |
905,131
-191,775
| -17% | -$618K | ﹤0.01% | 3298 |
|
|
2022
Q2 | $4.46M | Buy |
1,096,906
+649,000
| +145% | +$2.64M | ﹤0.01% | 3151 |
|
|
2022
Q1 | $2.21M | Buy |
447,906
+156,106
| +53% | +$771K | ﹤0.01% | 3522 |
|
|
2021
Q4 | $2.94M | Buy |
+291,800
| New | +$2.94M | ﹤0.01% | 3499 |
|